Ethypharm SA

Since 1977, Ethypharm has provided Innovative Drug Delivery Solutions to the pharmaceutical and biotech industry using proprietary formulations technologies.
The company designs its products to release the optimal concentration of the therapeutic compound in the body through precise targeting, timing and delivery.
Ethypharm is able to perform all aspects of modified release product development, including feasibility, scale-up, pharmacokinetic and clinical testing, registration and manufacturing. In addition to enhancing the performance and competitiveness of existing drugs, Ethypharm is able to meet the challenges posed by the delivery of NCEs and biotechnology products. The company currently has more than 120 pharmaceutical partners worldwide. Ethypharm is considered Europe's leader in drug delivery technologies. With four manufacturing sites and five development centers worldwide, Ethypharm has now expanded into North America. Ethypharm employs more than 700 people in eight countries.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Drug delivery
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Europe , North America

c. Countries active:

Corporate data:

Number of Employees: 700

Turnover:

Amount:	Year:	Currency:

Year founded: